REDEMPLO FDA approval date
The FDA approved REDEMPLO on 18 Nov 2025.
- FDA approval date
- 18 Nov 2025
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as PLOZASIRAN SODIUM
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2025-11-18Day | REDEMPLO | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA219947", "applicant_as_listed_by_fda": "ARROWHEAD", "brand_names": ["REDEMPLO"], "active_ingredients": ["PLOZASIRAN SODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20251118", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |